Skip to main content
. Author manuscript; available in PMC: 2018 Jul 15.
Published in final edited form as: Clin Cancer Res. 2017 Feb 7;23(14):3592–3600. doi: 10.1158/1078-0432.CCR-16-2629

Figure 2. Flavopiridol Exposure-Response: Probability of Clinical Response versus Quartiles of Flavopiridol Unbound AUC (h*ng/mL) for A) All Patients or B) Patients Stratified by Disease History.

Figure 2

Quartiles of flavopiridol unbound AUC were plotted as the median of the quartile. Vertical bars are the 95% confidence interval for probability of clinical response.